Literature DB >> 6324704

Impaired polymorphonuclear leucocyte chemotaxis in rheumatoid arthritis.

D H Goddard, A P Kirk, J R Kirwan, G D Johnson, E J Holborow.   

Abstract

This study has investigated the chemotactic activity of polymorphonuclear cells (PMNs) isolated from the blood of patients with either articular rheumatoid arthritis (RA) or RA with extra-articular manifestations. A double fluorochrome immunofluorescent staining test has been employed to identify cell-associated immunoglobulins, probably immune complexes. The results suggest an inverse relationship between PMN chemotaxis and staining for cell-associated immunoglobulins, either surface bound or internalised. PMNs from RA patients showed reduced chemotaxis, and this was further reduced when RA PMNs were incubated for 30 minutes in autologous serum. A similar reduction in chemotaxis of normal PMNs occurred after incubation in RA sera. Preincubation of both RA and normal PMNs in RA serum (but not normal serum) resulted in an increase in the number of cells in which cell-associated immunoglobulins were demonstrable. This further reduction in RA PMN chemotaxis after exposure to autologous serum, together with an increase in immunoglobulin staining, may indicate selection of certain PMNs at the time of venepuncture due to cell margination. Such a selection process would call for a re-evaluation of previous studies of RA PMN function in relation to the disease process.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6324704      PMCID: PMC1001454          DOI: 10.1136/ard.43.2.151

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN: 0003-4967            Impact factor:   19.103


  19 in total

1.  The conjugation of immunoglobulins with tetramethylrhodamine isothiocyanate. A comparison between the amorphous and the crystalline fluorochrome.

Authors:  L Amante; A Ancona; L Forni
Journal:  J Immunol Methods       Date:  1972-05       Impact factor: 2.303

2.  A serum inhibitor of leukotaxis in a child with recurrent infections.

Authors:  C W Smith; J C Hollers; E Dupree; A S Goldman; R A Lord
Journal:  J Lab Clin Med       Date:  1972-06

3.  The formation of immunoglobulins by human tissues in vitro. I. The methods and their specificity.

Authors:  R van Furth; R E Schuit; W Hijmans
Journal:  Immunology       Date:  1966-07       Impact factor: 7.397

4.  Characterization of serum inhibitors of neutrophil chemotaxis associated with anergy.

Authors:  D E Van Epps; D L Palmer; R C Williams
Journal:  J Immunol       Date:  1974-07       Impact factor: 5.422

5.  Defective regulation of inflammatory mediators in Hodgkin's disease. Supernormal levels of chemotactic-factor inactivator.

Authors:  P A Ward; J L Berenberg
Journal:  N Engl J Med       Date:  1974-01-10       Impact factor: 91.245

6.  Defective chemotaxis associated with a serum inhibitor in cirrhotic patients.

Authors:  A N DeMeo; B R Andersen
Journal:  N Engl J Med       Date:  1972-04-06       Impact factor: 91.245

7.  Inhibitors of leukocyte chemotaxis in alcoholic liver disease.

Authors:  D E Van Epps; R G Strickland; R C Williams
Journal:  Am J Med       Date:  1975-08       Impact factor: 4.965

8.  Leukotactic dystunction in sarcoidosis.

Authors:  E G Maderazo; P A Ward; C L Woronick; J Kubik; A C DeGraff
Journal:  Ann Intern Med       Date:  1976-04       Impact factor: 25.391

9.  Chemotaxis of polymorphonuclear leukocytes from patients with rheumatoid arthritis.

Authors:  A G Mowat; J Baum
Journal:  J Clin Invest       Date:  1971-12       Impact factor: 14.808

10.  Leukocyte locomotion and chemotaxis. New methods for evaluation, and demonstration of a cell-derived chemotactic factor.

Authors:  S H Zigmond; J G Hirsch
Journal:  J Exp Med       Date:  1973-02-01       Impact factor: 14.307

View more
  9 in total

1.  Chemotaxis and chemiluminescence responses of synovial fluid polymorphonuclear leucocytes during acute reactive arthritis.

Authors:  M Leirisalo-Repo; A Lauhio; H Repo
Journal:  Ann Rheum Dis       Date:  1990-08       Impact factor: 19.103

2.  Changes in normal polymorphonuclear leucocyte motility after ingestion of IgG aggregates.

Authors:  D H Goddard; A P Kirk; K A Brown; D McCarthy; G D Johnson; E J Holborow
Journal:  Ann Rheum Dis       Date:  1984-04       Impact factor: 19.103

3.  Migratory activity of blood polymorphonuclear leukocytes during juvenile rheumatoid arthritis, demonstrated with a new whole-blood membrane filter assay.

Authors:  G Egger; C Klemt; S Spendel; W Kaulfersch; H Kenzian
Journal:  Inflammation       Date:  1994-08       Impact factor: 4.092

4.  Intracellular demonstration of active TGFbeta1 in B cells and plasma cells of autoimmune mice. IgG-bound TGFbeta1 suppresses neutrophil function and host defense against Staphylococcus aureus infection.

Authors:  T E Caver; F X O'Sullivan; L I Gold; H D Gresham
Journal:  J Clin Invest       Date:  1996-12-01       Impact factor: 14.808

5.  Functions of polymorphonuclear leukocytes in early rheumatoid arthritis.

Authors:  M Leirisalo-Repo; L Paimela; S Koskimies; H Repo
Journal:  Inflammation       Date:  1993-08       Impact factor: 4.092

6.  Synovial fluid neutrophils of patients with rheumatoid arthritis have membrane antigen changes that reflect activation.

Authors:  P Emery; A F Lopez; G F Burns; M A Vadas
Journal:  Ann Rheum Dis       Date:  1988-01       Impact factor: 19.103

7.  RA-map: building a state-of-the-art interactive knowledge base for rheumatoid arthritis.

Authors:  Vidisha Singh; George D Kalliolias; Marek Ostaszewski; Maëva Veyssiere; Eleftherios Pilalis; Piotr Gawron; Alexander Mazein; Eric Bonnet; Elisabeth Petit-Teixeira; Anna Niarakis
Journal:  Database (Oxford)       Date:  2020-01-01       Impact factor: 3.451

8.  Abnormal directed migration of blood polymorphonuclear leukocytes in rheumatoid arthritis. Potential role in increased susceptibility to bacterial infections.

Authors:  F Aglas; J Hermann; G Egger
Journal:  Mediators Inflamm       Date:  1998       Impact factor: 4.711

9.  Spontaneous elaboration of transforming growth factor beta suppresses host defense against bacterial infection in autoimmune MRL/lpr mice.

Authors:  J H Lowrance; F X O'Sullivan; T E Caver; W Waegell; H D Gresham
Journal:  J Exp Med       Date:  1994-11-01       Impact factor: 14.307

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.